Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.053 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.059 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |